Blood substitute beneficial for trauma patients:
This article was originally published in Clinica
Northfield Laboratories' oxygen-carrying blood substitute PolyHeme improves survival rates in trauma situations where blood might not be available, the company told the US Health and Human Services Advisory Committee on Blood Safety and Availability. In an assessment of 53 patients, none of whom received blood from a blood bank during the study, 85% survived after infusions of the modified haemoglobin, essentially the same percentage that would have been expected to survive if banked blood had been used, said the Evanston Illinois-based company. PolyHeme is undergoing trials for both trauma and surgery.
You may also be interested in...
Dr Reddy's is poised to expand its OTC offering in Russia and certain CIS countries by snapping up a basket of allergy brands from fellow Indian firm Glenmark.
Sandoz has launched an awareness campaign under the banner of “Ask For Generics” in the US. The initiative is aiming to educate stakeholders on the benefits of generics and their quality, safety and efficacy.
European Commission proposals for strengthening intellectual property protections in the EU, particularly the supplementary protection certificate (SPC) system, have been broadly welcomed by Europe’s brand industry. But the medical NGO, MSF, says the SPC proposals run counter to the commission’s own efforts to improve access to medicines.